Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
Mutation in gyrA leads to quinolone resistance
Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
Mutations in gyrA were associated with increased resistance to fluoroquinolones.
Horizontal transfer of fluoroquinolone resistance genes in Streptococcus pneumoniae
Mutations in gyrA are associated with fluoroquinolone resistance.
Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.
mutations in quinolone resistance-determining region associated with resistance to fluoroquinolones
Rapid pneumococcal evolution in response to clinical interventions.
Clonal spread of levofloxacin-resistant streptococcus pneumoniae invasive isolates in Madrid, Spain, 2007 to 2009.
Present in 21 isolates
Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.
Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.
Contributions of the 8-Methoxy Group of Gatifloxacin to Resistance Selectivity, Target Preference, and Antibacterial Activity against Streptococcus pneumoniae.
In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.
Mutations in gyrA are associated with quinolone resistance.
Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.
Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin.
Pneumococci can persistently colonize adult patients with chronic respiratory disease.
Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B Streptococcus from South Korea.
Mutations in gyrA were associated with fluoroquinolone resistance.
Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain.
Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.
Mutations in gyrA transformed S. pneumoniae only when mutations in parC were present
Allele-specific collateral and fitness effects determine the dynamics of fluoroquinolone resistance evolution.
Mutations in gyrA contribute to fluoroquinolone resistance in S. pneumoniae.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research